Collection 5 (Sep 2024 - Aug 2025) Articles

Articles
Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography
Han D, Tzolos E, Park R, et al.
Journal:
JACC Cardiovasc Imaging

First published: April 2, 2025 DOI: 10.1016/j.jcmg.2025.01.005
View
- Share
Articles
Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study
Kraaijenhof JM, Nurmohamed NS, Nordestgaard AT, et al.
Journal:
Eur Heart J

First published: April 1, 2025 DOI: 10.1093/eurheartj/ehaf209
View
- Share
Articles
An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial
Koren MJ, Vega RB, Agrawal N, et al.
Journal:
J Am Coll Cardiol

First published: March 31, 2025 DOI: 10.1016/j.jacc.2025.03.499
View
- Share
Articles
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
Ray KK, Oru E, Rosenson RS, et al.
Journal:
Lancet

First published: March 31, 2025 DOI: 10.1016/S0140-6736(25)00507-0
View
- Share
Articles
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies
Ray KK, Linnebjerg H, Michael LF, et al.
Journal:
J Am Coll Cardiol

First published: March 30, 2025 DOI: 10.1016/j.jacc.2025.03.005
View
- Share
Articles
Lepodisiran – A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
Nissen SE, Ni W, Shen X, et al.
Journal:
N Engl J Med

First published: March 30, 2025 DOI: 10.1056/NEJMoa2415818
View
- Share
Articles
Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis
Yong Y, Giovannucci J, Pang SN, et al.
Journal:
JACC Cardiovasc Imaging

First published: March 18, 2025 DOI: 10.1016/j.jcmg.2024.07.024
View
- Share
Articles
Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies
Watts GF, Chan DC
Journal:
Eur Heart J

First published: March 4, 2025 DOI: 10.1093/eurheartj/ehae931
View
- Share
Articles
2025 Consensus on the Clinical Pathway of Blood Cholesterol Management in Taiwan
Li YH, Shih CL
Journal:
Acta Cardiol Sin

First published: March 1, 2025 DOI: 10.6515/ACS.202503_41(2).20250215A
View
- Share
Articles
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Rao SV, O’Donoghue ML, Ruel M, et al.
Journal:
Circulation

First published: February 27, 2025 DOI: 10.1161/CIR.0000000000001309
View
- Share
Articles
Distinct inflammatory pathways shape atherosclerosis in different vascular beds
Soehnlein O, Lutgens E, Döring Y
Journal:
Eur Heart J

First published: February 27, 2025 DOI: 10.1093/eurheartj/ehaf054
View
- Share
Articles
Reappraisal of statin primary prevention trials: implications for identification of the statin-eligible primary prevention patient
Mancini GBJ, Ryomoto A, Yeoh E, et al.
Journal:
Eur J Prev Cardiol

First published: February 25, 2025 DOI: 10.1093/eurjpc/zwaf048
View
- Share

1 2 3 … 5

Collection 5 (Sep 2024 - Aug 2025) Articles

Articles

Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography

Han D, Tzolos E, Park R, et al.

Articles

Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study

Kraaijenhof JM, Nurmohamed NS, Nordestgaard AT, et al.

Articles

An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial

Koren MJ, Vega RB, Agrawal N, et al.

Articles

Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial

Ray KK, Oru E, Rosenson RS, et al.

Articles

Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies

Ray KK, Linnebjerg H, Michael LF, et al.

Articles

Lepodisiran – A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)

Nissen SE, Ni W, Shen X, et al.

Articles

Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis

Yong Y, Giovannucci J, Pang SN, et al.

Articles

Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies

Watts GF, Chan DC

Articles

2025 Consensus on the Clinical Pathway of Blood Cholesterol Management in Taiwan

Li YH, Shih CL

Articles

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Rao SV, O’Donoghue ML, Ruel M, et al.

Articles

Distinct inflammatory pathways shape atherosclerosis in different vascular beds

Soehnlein O, Lutgens E, Döring Y

Articles

Reappraisal of statin primary prevention trials: implications for identification of the statin-eligible primary prevention patient

Mancini GBJ, Ryomoto A, Yeoh E, et al.

Articles

Effects of Evolocumab on Coronary Plaque Composition and Microcalcification Activity by Coronary PET and CT Angiography

Han D, Tzolos E, Park R, et al.

Share

Articles

Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study

Kraaijenhof JM, Nurmohamed NS, Nordestgaard AT, et al.

Share

Articles

An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial

Koren MJ, Vega RB, Agrawal N, et al.

Share

Articles

Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial

Ray KK, Oru E, Rosenson RS, et al.

Share

Articles

Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies

Ray KK, Linnebjerg H, Michael LF, et al.

Share

Articles

Lepodisiran – A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)

Nissen SE, Ni W, Shen X, et al.

Share

Articles

Coronary Artery Calcium Density and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis

Yong Y, Giovannucci J, Pang SN, et al.

Share

Articles

Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies

Watts GF, Chan DC

Share

Articles

2025 Consensus on the Clinical Pathway of Blood Cholesterol Management in Taiwan

Li YH, Shih CL

Share

Articles

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Rao SV, O’Donoghue ML, Ruel M, et al.

Share

Articles

Distinct inflammatory pathways shape atherosclerosis in different vascular beds

Soehnlein O, Lutgens E, Döring Y

Share

Articles

Reappraisal of statin primary prevention trials: implications for identification of the statin-eligible primary prevention patient

Mancini GBJ, Ryomoto A, Yeoh E, et al.

Share